Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17947
Country/Region: Kenya
Year: 2016
Main Partner: Amref Health Africa
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,175,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Laboratory Infrastructure (HLAB) $900,000
Biomedical Prevention: Blood Safety (HMBL) $95,000
Biomedical Prevention: Injection Safety (HMIN) $180,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
LAB_PT CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 42
LAB_PT CD4: Number of laboratories that participate in this PT program 2017 53
LAB_PT CD4: Number of laboratories that perform this testing 2017 53
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 54
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 67
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 67
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 54
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that participate in this PT program 2017 67
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that perform this testing 2017 67
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 18
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that participate in this PT program 2017 23
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that perform this testing 2017 23
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 6
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 13
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 14
Cross Cutting Budget Categories and Known Amounts Total: $229,286
Motor Vehicles: Purchased $179,286
Renovation $50,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research